Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|April 21, 2023
Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in NigeriaChinwe Lucia Ochu, Lorretta Ntoimo, Ikenna Onoh, et al.
BMJ Global Health|November 30, 2023
Mpox (monkeypox) risk and mortality associated with HIV infection: a national case-control study in NigeriaAdesola Yinka-Ogunleye, Mahmood Dalhat, Afolabi Akinpelu, et al.
Vaccines|March 30, 2023
Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?Rania A Tohme, Heather M Scobie, Oyeladun Okunromade, et al.
Vaccine|February 21, 2022
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global useErin Sparrow, Ifedayo Adetifa, Nathorn Chaiyakunapruk, et al.
BMC Genomics|October 14, 2025
Genomic diversity and surveillance of SARS-CoV-2 in NigeriaThomas J Y Kono, Ezenwa J Onyemata, Natalia Blanco, et al.
Wellcome Open Research|April 4, 2022
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)Michael Abouyannis, Richard FitzGerald, Mwanajuma Ngama, et al.
Plos One|December 30, 2022
Epidemiological trends of Lassa fever in Nigeria, 2018-2021Mahmood M Dalhat, Adebola Olayinka, Martin M Meremikwu, et al.
Science (New York, N.Y.)|November 2, 2023
APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016Áine O'Toole, Richard A Neher, Nnaemeka Ndodo, et al.
Ebiomedicine|February 28, 2025
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adultsMichael Abouyannis, Yvonne K Nyambura, Samson Ngome, et al.
The American Journal of Tropical Medicine and Hygiene|November 27, 2023
Schistosomiasis Seroprevalence among Children Aged 0-14 Years in Nigeria, 2018Anne Straily, Israel Tamunonengiyeofori, Ryan E Wiegand, et al.
Pageof 6